Gene therapy for neurodegenerative diseases targeting microRNA and others
DNA Sequence
01AAV vector as a delivering vehicle
02Single injection
03Long-lasting effect
04Safe arrival of transgenes into nuclei is all about gene therapy drugs
ANLBIO answers tocommercial challenges of gene therapy modalities with an innovative
delivery platform of viral vectors including AAV
Enhanced Random Mutagenesis System (ERMS)
01Mutation of capsid protein at multiple position
02Revamped screening by barcode & deep sequencing
03Capsid protein library
04